FindTrial
Sign In

Evaluation of markers in liver cirrhosis

Evaluation of inflammatory,hepatic enzyme,lipid and protein biomarkers in liver cirrhosis:An integrated approach beyond MELD score - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/111964
Enrollment
55
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

Intervention1: Nil: Nil

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age more than 18 years 2.Diagnosed liver cirrhosis 3.Both genders

Exclusion criteria

Exclusion criteria: 1.Hepatocellular carcinoma 2.Acute liver failure 3.Severe renal disease 4.Patients on lipid lowering drugs

Design outcomes

Primary

MeasureTime frame
Integrated biomarkers will show better correlation with disease severity than MELD score.Timepoint: Assessment will be done at weekly and overall assessment will be done in two years—

Secondary

MeasureTime frame
hs CRP correlates with inflammationTimepoint: Assessment will be done at weekly and overall assessment will be done in two years—

Countries

India

Contacts

Public ContactDr. Ashish Anjankar

Datta Meghe Institute of Higher Education and Research

ashish.anjankar@dmiher.edu.in9970951055

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026